Precigen

Precigen is a Maryland-based clinical stage biopharmaceutical company that develops gene and cellular therapies for the treatment of immuno-oncology and autoimmune disorders.

Business Model:

Revenue: $138.8M

Employees: 201-500

Detailed Precigen Information

Geographic Data

Precigen headquarters map

Address: 20358 Seneca Meadows Parkway

City: Germantown

State: MD

Zip: 20876

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$129M

Raised Total:

$526M

Metrics

4,151,259Website Global Rank

2,725Website Monthly Traffic

Twitter Followers

Description

Precigen is a Maryland-based clinical stage biopharmaceutical company that develops gene and cellular therapies for the treatment of immuno-oncology and autoimmune disorders.

Contact Phone:
+13015569900

Contact Email:

Precigen went public on 8/13/2013 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
8/13/2013

Ticker Symbol:
PGEN

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
12/2014 Histogenics Post-IPO Equity 0
12/2014 Histogenics Post-IPO Equity 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Announced Date Transaction Number of Investors Money Raised Lead Investors
3/2006 Venture Round $0 NewVa Capital Partners
NewVa Capital Partners
NewVa Capital Partners
NewVa Capital Partners
5/2011 Series E $0 Randal J. Kirk
NewVa Capital Partners
Third Security
Randal J. Kirk
NewVa Capital Partners
Third Security
1/2015 Post-IPO Equity $57.5M
7/2009 Series C $10M
12/2020 Post-IPO Equity $13M
1/2023 Post-IPO Equity $75M
2/2016 Post-IPO Equity $4.3M
1/2020 Post-IPO Equity $35M
9/2015 Post-IPO Equity $21.6M
5/2007 Series C 1 $25M Third Security
Third Security
Third Security
Third Security
5/2013 Series F $0 Randal J. Kirk
Third Security
Randal J. Kirk
Third Security
1/2021 Post-IPO Equity $129.4M
1/2023 Post-IPO Equity $75M
2/2020 Post-IPO Equity $35M
5/2005 Series B 1 $500k Third Security
Third Security
3/2010 Series D $17.4M
5/2013 Series F 2 $150M Randal J. Kirk
Third Security
Randal J. Kirk
Third Security
5/2011 Series E 3 $100M Randal J. Kirk
NewVa Capital Partners
Third Security
Randal J. Kirk
NewVa Capital Partners
Third Security
3/2006 Venture Round 1 $1M NewVa Capital Partners
NewVa Capital Partners
NewVa Capital Partners
NewVa Capital Partners
Announced Date Name Price
1/2017 GenVec
2/2016 EnviroFlight
8/2015 Oxitec
2/2015 ActoGeniX
12/2013 Medistem
10/2011 Immunologix
2/2011 Agarigen, Inc

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research